Purple Biotech (PPBT) Free Cash Flow (2017 - 2026)
Purple Biotech (PPBT) reported Free Cash Flow of -$3.1 million for Q1 2026, down 57.79% year-over-year from -$7.4 million in Q1 2025, and down 192.5% quarter-over-quarter from -$1.1 million in Q4 2025.
Purple Biotech (PPBT) Free Cash Flow (2017 - 2026) Analysis & Trends
Purple Biotech (PPBT) has 10 years of Free Cash Flow data on file, last reported at -$3.1 million in Q1 2026.
- Free Cash Flow for Q1 2026 came in at -$3.1 million, down 57.79% year-over-year; the trailing twelve-month figure through Mar 2026 was -$6.8 million (up 39.63% YoY), and the FY2025 annual result was -$5.7 million, up 60.61% from the prior year.
- Free Cash Flow slipped to -$3.1 million in Q1 2026 per PPBT's latest filing, from -$1.1 million in the prior quarter.
- Over five years, Free Cash Flow peaked at -$1.1 million in Q3 2025 and troughed at -$6.1 million in Q1 2023.
- A 5-year average of -$3.5 million and a median of -$3.7 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow soared 67.62% in 2025, then tumbled 57.79% in 2026.
- A 5-year view of Free Cash Flow shows it stood at -$4.3 million in 2022, then fell by 16.92% to -$5.0 million in 2023, then surged by 59.62% to -$2.0 million in 2024, then soared by 47.02% to -$1.1 million in 2025, then plunged by 192.5% to -$3.1 million in 2026.
- Business Quant data shows PPBT's Free Cash Flow at -$3.1 million in Q1 2026, -$1.1 million in Q4 2025, and -$1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 63,220.27 |
| 10 | Purple Biotech | 242.86 Mn | 236.43 Mn | - | -3.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.12 Mn |
| Mar 31, 2026 | -3.12 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Dec 31, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Sep 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Jun 30, 2025 | -1.54 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Mar 31, 2025 | -1.98 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Dec 31, 2024 | -2.01 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Sep 30, 2024 | -3.30 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Mar 31, 2024 | -5.08 Mn |
| Dec 31, 2023 | -4.99 Mn |
| Dec 31, 2023 | -4.99 Mn |